Hong Kong biotech: from niche exposure to broader product ecosystem
|
Hong Kong's
biotech market is maturing from a niche thematic allocation into a broader
capital markets proposition. |
Hong Kong's affluent planning lags despite wealth continuity gains
Hong Kong 's high-net-worth (HNW) families generally understood the risks linked to longer lifespans, but many had not fully implemented formal ... View article...